EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Modeling Protein–Protein and Protein–Ligand Interactions by the ClusPro Team in CASP16

Ryota Ashizawa, Sergei Kotelnikov, Omeir Khan, Stan Xiaogang Li, Ernest Glukhov, Xin Cao, Maria Lazou, Ayse Bekar‐Cesaretli, Derara Hailegeorgis, Veranika Averkava, Yimin Zhu, George Jones, Hao Yu, Dmytro Kalitin, Darya Stepanenko, Kushal Koirala, Taras Patsahan, Dmitri Beglov, Mark Lukin, Diane Joseph‐McCarthy, Carlos Simmerling, Alexander Tropsha, Evangelos Coutsias, Ken A. Dill, Dzmitry Padhorny, Sandor Vajda, Dima Kozakov

Proteins: Structure, Function, and Bioinformatics · 2026-01 · 94 (1) · 183-191

DOI: 10.1002/prot.70066 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT In the CASP16 experiment, our team employed hybrid computational strategies to predict both protein–protein and protein–ligand complex structures. For protein–protein docking, we combined physics‐based sampling—using ClusPro FFT docking and molecular dynamics—with AlphaFold (AF)‐based sampling, followed by AF‐based refinement. Our method produced numerous high‐accuracy complex models, including cases where AF alone failed, underscoring the critical role of physics‐based sampling alongside deep learning‐based refinement. For protein–ligand docking, we integrated the ClusPro LigTBM template‐based approach with a machine learning‐based confidence model for rescoring. The method preserves conserved interaction fragments derived from homologous complexes, followed by local resampling using physics‐based sampling and a diffusion model. Our template‐based strategy achieved a mean lDDT‐PLI of 0.69 across 233 targets, which was highly competitive. These results demonstrate that combining physics‐based modeling with AI‐driven refinement can significantly enhance the accuracy of both protein–protein and protein–ligand structure predictions.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →